Virtu Financial LLC Aprea Therapeutics, Inc. Transaction History

Virtu Financial LLC

$1.82 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 09, 2022	BUY	$0.62 - $1.94 $3,613 - $11,308	5,829 Added 42.13%	19,664 $15,000
Q1 2022 May 17, 2022	SELL	$1.59 - $3.16 $44,710 - $88,859	-28,120 Reduced 67.02%	13,835 $26,000
Q4 2021 Feb 17, 2022	BUY	$2.87 - $5.58 $120,410 - $234,108	41,955 New	41,955 $120,000
Q3 2021 Nov 12, 2021	SELL	$3.43 - $5.63 $141,117 - $231,629	-41,142 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$4.05 - $5.5 $124,217 - $168,690	30,671 Added 292.91%	41,142 $201,000
Q1 2021 May 19, 2021	SELL	$4.73 - $8.15 $64,129 - $110,497	-13,558 Reduced 56.42%	10,471 $53,000
Q4 2020 Feb 24, 2021	BUY	$4.92 - $30.67 $118,222 - $736,969	24,029 New	24,029 $118,000

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$3,865
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.